Inmed Pharmaceuticals Inc. · NASDAQ:INM

Vivo Opportunity, LLC bought 249,227 Inmed Pharmaceuticals Inc. shares (Form 4)

Traded May 20 to Jun 8, 2026 · Filed Jun 10, 2026

From May 20 to Jun 8, 2026, Vivo Opportunity, LLC (10% owner) bought 249,227 Inmed Pharmaceuticals Inc. shares at an average US$1.57 for US$392K, leaving 72,535 shares. Filed Jun 10, 2026 (Form 4).

Bought
249,227 shares
Price
US$1.57 average (US$1.52 to US$1.69)
Value
US$392K
Holding after
72,535 shares (held indirectly)
Trading plan
No
Role
10% owner

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 20, 2026Common SharesBuy51,056US$1.56543,129Indirect
May 20, 2026Common SharesBuy5,154US$1.5654,833Indirect
May 21, 2026Common SharesBuy30,882US$1.69574,011Indirect
May 21, 2026Common SharesBuy3,118US$1.6957,951Indirect
May 29, 2026Common SharesBuy16,164US$1.57590,175Indirect
May 29, 2026Common SharesBuy1,632US$1.5759,583Indirect
Jun 1, 2026Common SharesBuy14,838US$1.55605,013Indirect
Jun 1, 2026Common SharesBuy1,498US$1.5561,081Indirect
Jun 2, 2026Common SharesBuy20,753US$1.52625,766Indirect
Jun 2, 2026Common SharesBuy2,095US$1.5263,176Indirect
Jun 3, 2026Common SharesBuy7,069US$1.55632,835Indirect
Jun 3, 2026Common SharesBuy714US$1.5563,890Indirect
Jun 4, 2026Common SharesBuy6,125US$1.57638,960Indirect
Jun 4, 2026Common SharesBuy618US$1.5764,508Indirect
Jun 5, 2026Common SharesBuy49,966US$1.57688,926Indirect
Jun 5, 2026Common SharesBuy5,045US$1.5769,553Indirect
Jun 8, 2026Common SharesBuy29,518US$1.52718,444Indirect
Jun 8, 2026Common SharesBuy2,982US$1.5272,535Indirect

Source

View original at SEC

Related